Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine

被引:3
作者
Dionisio, Joana Moniz [1 ]
Santos, Mariana [1 ]
Rodrigues, Ana Martins [2 ]
Rego, Andre [1 ]
Vitor, Joana [2 ]
Delgado, Sofia [1 ]
Pinheiro, Rita [1 ]
Neves, Pedro [1 ]
Figueiredo, Carlos [1 ]
Costa, Jose Bandeira [1 ,3 ]
Vale, Jose [2 ]
Salgado, Vasco [1 ]
Timoteo, Angela [2 ]
机构
[1] Hosp Prof Doutor Fernando Fonseca, Neurol Dept, Amadora, Portugal
[2] Hosp Beatriz Angelo, Loures, Portugal
[3] Inst Portugues Oncol Francisco Gentil Lisbon, Lisbon, Portugal
关键词
multiple sclerosis; COVID-19; pandemic; vaccines; opinions; questionnaire;
D O I
10.1016/j.msard.2021.103113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. METHODS: Observational study, based on a cross-sectional (10-20th September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize the sample and a questionnaire designed to assess the topics defined for this study. RESULTS: 270 respondents completed the full survey (response rate 58.2%). pwMS greatest concern during the pandemic was an aggravation of MS, especially by patients older than 50 years old. Almost 40% of the patients older than 50 felt that the pandemic negatively affected their MS related medical assistance. Most patients believed they would recover from COVID-19 infection. More than half of the responders feared a MS aggravation if they got COVID-19; this was more pronounced in patients with progressive MS. About 12% of the participants did not want to be vaccinated and almost 40% was unsure. Regarding vaccines in general, almost a third of the participants feared their side effects or MS related complications. CONCLUSION: Having knowledge of pwMS' opinions on COVID-19 pandemic impact and vaccination is useful to better address these issues. Fears and expectations towards vaccination must be discussed with pwMS.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
    Toljan, Karlo
    Amin, Moein
    Kunchok, Amy
    Ontaneda, Daniel
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [42] Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic
    Rath, Louise
    Bui, Minh Viet
    Ellis, Julian
    Carey, John
    Baker, Josephine
    Taylor, Lisa
    Fernando, Hasini
    Taylor, Nicola
    Savage, Poppy
    Richards, Janene
    Zhong, Michael
    Kalincik, Tomas
    Skibina, Olga
    Wesselingh, Robb
    Nguyen, Ai-Lan
    Monif, Mastura
    Butzkueven, Helmut
    van der Walt, Anneke
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [43] Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic
    Hernandez-Garcia, Ignacio
    Garces-Redondo, Moises
    Espinosa-Rueda, Judit
    Rodriguez-Montolio, Joana
    Bengoa-Urrengoechea, Irantzu
    Aibar-Remon, Carlos
    VACCINES, 2022, 10 (10)
  • [44] Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic
    Sbragia, Elvira
    Colombo, Eleonora
    Pollio, Chiara
    Cellerino, Maria
    Lapucci, Caterina
    Inglese, Matilde
    Mancardi, Gianluigi
    Boffa, Giacomo
    PSYCHOLOGY HEALTH & MEDICINE, 2022, 27 (02) : 352 - 360
  • [45] Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic
    Baba, Cavid
    Yigit, Pinar
    Dastan, Seda
    Hancer, Pelin
    Sagici, Ozge
    Ozakbas, Serkan
    Abasiyanik, Zuhal
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (01): : 3 - 8
  • [46] COVID-19 in ocrelizumab-treated people with multiple sclerosis
    Hughes, Richard
    Whitley, Louise
    Fitovski, Kocho
    Schneble, Hans-Martin
    Muros, Erwan
    Sauter, Annette
    Craveiro, Licinio
    Dillon, Paul
    Bonati, Ulrike
    Jessop, Nikki
    Pedotti, Rosetta
    Koendgen, Harold
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [47] COVID-19 vaccination in people with multiple sclerosis, real-life experience
    Alroughani, Raed
    Al-Hashel, Jasem
    Abokalawa, Fathi
    AlMojel, Malak
    Ahmed, Samar Farouk
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 220
  • [48] Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
    Allen-Philbey, K.
    Stennett, A.
    Begum, T.
    Johnson, AC.
    Dobson, R.
    Giovannoni, G.
    Gnanapavan, S.
    Marta, M.
    Smets, I.
    Turner, B. P.
    Baker, D.
    Mathews, J.
    Schmierer, K.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [49] COVID-19 vaccination willingness among people with multiple sclerosis
    Xiang, Xinran M.
    Hollen, Chris
    Yang, Qian
    Brumbach, Barbara H.
    Spain, Rebecca, I
    Wooliscroft, Lindsey
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [50] Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic
    Alschuler, Kevin N.
    Roberts, Michelle K.
    Herring, Tracy E.
    Ehde, Dawn M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47